Alpha 2.0
Login Register
» Articles » PMID: 10513659

Intralesional or Topical Cidofovir (HPMPC, VISTIDE) for the Treatment of Recurrent Genital Warts in HIV-1-infected Patients

Overview
Journal AIDS
Specialty Infectious Diseases
Date 1999 Oct 8
PMID 10513659
Citations 5
Authors
G Orlando
M M Fasolo
R Beretta
R Signori
B Adriani
N Zanchetta
A Cargnel
Affiliations
Soon will be listed here.
Citing Articles

Cutaneous Applications of the Antiviral Drug Cidofovir: A Review.

Poppens M, Ruci A, Davis J J Clin Med. 2024; 13(9).

PMID: 38730991 PMC: 11084884. DOI: 10.3390/jcm13092462.

Intralesional cidofovir for the management of refractory cutaneous verrucae: a review of applications and opportunities.

Lau W, Lau C, Frangos J, Nambudiri V Ther Adv Infect Dis. 2023; 10:20499361231165862.

PMID: 37056449 PMC: 10088403. DOI: 10.1177/20499361231165862.

Topical therapies for the treatment of anal high-grade squamous intraepithelial lesions.

Megill C, Wilkin T Semin Colon Rectal Surg. 2018; 28(2):86-90.

PMID: 29910593 PMC: 5999046. DOI: 10.1053/j.scrs.2017.04.006.

Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women.

Stier E, Goldstone S, Einstein M, Jay N, Berry J, Wilkin T AIDS. 2012; 27(4):545-51.

PMID: 23032420 PMC: 3759510. DOI: 10.1097/QAD.0b013e32835a9b16.

An armamentarium of wart treatments.

Lipke M Clin Med Res. 2007; 4(4):273-93.

PMID: 17210977 PMC: 1764803. DOI: 10.3121/cmr.4.4.273.